STRATA Skin Sciences, Inc. (NASDAQ:SSKN – Get Free Report) was the target of a large drop in short interest in the month of April. As of April 15th, there was short interest totalling 1,200 shares, a drop of 45.5% from the March 31st total of 2,200 shares. Based on an average trading volume of 3,100 shares, the short-interest ratio is presently 0.4 days. Approximately 0.1% of the company’s shares are short sold.
STRATA Skin Sciences Price Performance
Shares of SSKN stock opened at $2.61 on Tuesday. STRATA Skin Sciences has a 1-year low of $2.51 and a 1-year high of $5.10. The firm has a fifty day moving average of $2.65 and a two-hundred day moving average of $2.86. The company has a debt-to-equity ratio of 1.62, a current ratio of 1.13 and a quick ratio of 0.94. The firm has a market cap of $10.90 million, a P/E ratio of -0.98 and a beta of 1.08.
STRATA Skin Sciences (NASDAQ:SSKN – Get Free Report) last posted its earnings results on Thursday, March 27th. The medical device company reported ($1.13) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.40) by ($0.73). The firm had revenue of $33.56 million for the quarter, compared to analyst estimates of $9.03 million. STRATA Skin Sciences had a negative net margin of 28.72% and a negative return on equity of 69.33%. As a group, research analysts anticipate that STRATA Skin Sciences will post -1.05 earnings per share for the current fiscal year.
Analysts Set New Price Targets
Get Our Latest Stock Analysis on STRATA Skin Sciences
About STRATA Skin Sciences
STRATA Skin Sciences, Inc, a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment.
See Also
- Five stocks we like better than STRATA Skin Sciences
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- Disney: The Compelling Case for Buying Now Before They Scale Up
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- Best Defense Stocks in 2025… So Far
- A Deeper Look at Bid-Ask Spreads
- Alphabet Rebounds After Strong Earnings and Buyback Announcement
Receive News & Ratings for STRATA Skin Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STRATA Skin Sciences and related companies with MarketBeat.com's FREE daily email newsletter.